"People sometimes think that it's easier to trust a machine than it is to trust a person." Study makes troubling discovery ...

Discover how OpenAI and Sam Altman are leading the charge towards a future shaped by Artificial General Intelligence. The ...

In the lawsuit, filed in the British Columbia Supreme Court earlier this week, CanLII alleges that Caseway has created a ...

Researchers today are releasing the flagship dataset from an ambitious study of biomarkers and environmental factors that might influence the development of type 2 diabetes. Because the study ...

AI is already widespread and garnering billions of dollars in investment. But that doesn’t mean its ubiquity is predetermined ...

In an exclusive interview, Rahul Agarwalla, Managing Partner at SenseAI Ventures, shares insights on AI's impact on ...

DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.

When scientists approach artificial intelligence with creativity, it evolves from a mere tool into a dynamic partner in ...

Clinical trials play a pivotal role in the development and evaluation of new medical treatments, drugs, and therapies. These trials are subject to strict regulatory oversight to ensure participant ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter.

Demis Hassabis, joint winner of the Nobel Prize in Chemistry 2024, shared insights on AI at the FT Pharma and Biotech Summit.

Harnessing the power of artificial intelligence (AI) and the world's fastest supercomputers, a research team led by the U.S.